Trial intelligence / Profile preview

Safety and PK of IV Pregabalin and Acetaminophen in Healthy Volunteers

NCT04265456Phase 1Completed

Sponsor
Nevakar Inc.
Start
Jan 2020
Primary completion
Jun 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, double-blind trial of pregabalin in postoperative pain (3 arms), sponsored by Nevakar Inc. Primary endpoints: Treatment Related Adverse Events at 7 days and Treatment related Drowsiness and Dizziness at 7 days. Started Jan 2020; status: completed.

02

Drugs

pregabalin
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT04265456.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04265456.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call